Skip to main content
Erschienen in: Supportive Care in Cancer 1/2013

01.01.2013 | Original Article

Symptoms in advanced pancreatic cancer are of importance for energy intake

verfasst von: Asta Bye, Marit S. Jordhøy, Grete Skjegstad, Oddlaug Ledsaak, Per Ole Iversen, Marianne Jensen Hjermstad

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cancer cachexia and low energy intake (EI) probably contribute to weight loss in advanced pancreatic cancer (PC). However, little is known about the actual EI in this disease. Aims were to assess EI, weight loss and symptoms during the disease course and investigate associations between symptoms and EI.

Methods

Thirty-nine patients (21 males) with advanced PC were consecutively included and followed every 4 weeks until the end of life. A 24-h dietary recall was used to assess EI. The Edmonton Symptom Assessment System (ESAS) and the PC-specific health-related quality of life questionnaire (QLQ-PAN26) were used for symptom assessment.

Results

Median age was 62 years (48–88), WHO performance status 1 (0–2) and survival 5 months (1–25). Seventeen (44 %) patients had unresectable cancer, 16 (41 %) metastatic and six (15 %) recurrent disease. Upon inclusion, 37 (95 %) reported weight loss (median 4.0 kg per month). During follow-up, median weight loss per month was <1.0 kg. Forty to 65 % had EI <29 kcal/kg/day (cut-off value for weight maintenance) during the observation period but they did not lose more weight than patients with EI ≥ 29 kcal. Strong negative correlations (r range) were found between EI and pain (0.51–0.61), fatigue (0.54–0.67), oral dryness (0.61–0.64) and loss of appetite (0.53–0.71).

Conclusion

In this study, several symptoms influenced EI negatively. Low EI did not completely explain weight loss in this patient group, but careful monitoring and early follow-up of symptoms may be important interventions to reduce weight loss in advanced PC.
Literatur
1.
Zurück zum Zitat Wigmore SJ, Plester CE, Richardson RA, Fearon KC (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75(1):106–109PubMedCrossRef Wigmore SJ, Plester CE, Richardson RA, Fearon KC (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75(1):106–109PubMedCrossRef
3.
Zurück zum Zitat Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495 Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495
4.
Zurück zum Zitat Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46. doi:10.1007/s00520-006-0091-0 PubMedCrossRef Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46. doi:10.​1007/​s00520-006-0091-0 PubMedCrossRef
5.
Zurück zum Zitat Bovio G, Bettaglio R, Bonetti G, Miotti D, Verni P (2008) Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care. Minerva Gastroenterol Dietol 54(3):243–250PubMed Bovio G, Bettaglio R, Bonetti G, Miotti D, Verni P (2008) Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care. Minerva Gastroenterol Dietol 54(3):243–250PubMed
6.
7.
Zurück zum Zitat Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol, Corrected Proof. doi:DOI: 10.1016/j.critrevonc.2010.10.004 Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol, Corrected Proof. doi:DOI: 10.​1016/​j.​critrevonc.​2010.​10.​004
8.
Zurück zum Zitat Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A (2009) Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17(12):1531–1541. doi:10.1007/s00520-009-0623-5 PubMedCrossRef Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A (2009) Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17(12):1531–1541. doi:10.​1007/​s00520-009-0623-5 PubMedCrossRef
10.
Zurück zum Zitat Damerla V, Gotlieb V, Larson H, Saif MW (2008) Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol 6(8):393–396PubMed Damerla V, Gotlieb V, Larson H, Saif MW (2008) Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol 6(8):393–396PubMed
11.
Zurück zum Zitat Perez MM, Newcomer AD, Moertel CG, Go VL, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52(2):346–352PubMedCrossRef Perez MM, Newcomer AD, Moertel CG, Go VL, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52(2):346–352PubMedCrossRef
12.
Zurück zum Zitat Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG (2005) Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103(10):2189–2198PubMedCrossRef Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG (2005) Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103(10):2189–2198PubMedCrossRef
15.
Zurück zum Zitat Ferrucci L, Bell D, Thornton J, Black G, McCorkle R, Heimburger D, Saif M (2010) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer:1-6. doi:10.1007/s00520-010-1011-x Ferrucci L, Bell D, Thornton J, Black G, McCorkle R, Heimburger D, Saif M (2010) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer:1-6. doi:10.​1007/​s00520-010-1011-x
16.
Zurück zum Zitat Blaker B, Aarsland M (1989) Mål og vekt for matvarer. Landsforeningen for kosthold & helse, [Oslo] Blaker B, Aarsland M (1989) Mål og vekt for matvarer. Landsforeningen for kosthold & helse, [Oslo]
18.
Zurück zum Zitat Fagerli RA (2008) Matvaretabellen. Gyldendal undervisning, Oslo Fagerli RA (2008) Matvaretabellen. Gyldendal undervisning, Oslo
19.
Zurück zum Zitat Saxholt E, Christensen AT, Møller A, Hartkopp HB, Hess Ygil, K, Hels, OH (2008) Danish food composition databank, revision 7 Saxholt E, Christensen AT, Møller A, Hartkopp HB, Hess Ygil, K, Hels, OH (2008) Danish food composition databank, revision 7
21.
Zurück zum Zitat Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed
22.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
23.
Zurück zum Zitat Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Buchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35(6):939–941PubMedCrossRef Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Buchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35(6):939–941PubMedCrossRef
24.
Zurück zum Zitat Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, Chow E (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag 39(2):241–249CrossRef Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, Chow E (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag 39(2):241–249CrossRef
25.
Zurück zum Zitat Marin Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10(4):480–487PubMedCrossRef Marin Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10(4):480–487PubMedCrossRef
26.
Zurück zum Zitat Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 17(1):83–90PubMedCrossRef Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 17(1):83–90PubMedCrossRef
27.
Zurück zum Zitat Fayers PMAN, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual 3rd edn. EORTC Quality of Life Group Brussels, Belgium Fayers PMAN, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual 3rd edn. EORTC Quality of Life Group Brussels, Belgium
28.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum, Hillsdale Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum, Hillsdale
29.
Zurück zum Zitat Bovio G, Montagna G, Bariani C, Baiardi P (2009) Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status. Support Care Cancer 17(10):1317–1324PubMedCrossRef Bovio G, Montagna G, Bariani C, Baiardi P (2009) Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status. Support Care Cancer 17(10):1317–1324PubMedCrossRef
30.
Zurück zum Zitat Gibson RS (2005) Principles of nutritional assessment. Oxford University Press, New York Gibson RS (2005) Principles of nutritional assessment. Oxford University Press, New York
31.
Zurück zum Zitat Johnson G, Salle A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud J-P, Malthiery Y, Simard G, Ritz P (2008) Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 24(5):443–450PubMedCrossRef Johnson G, Salle A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud J-P, Malthiery Y, Simard G, Ritz P (2008) Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 24(5):443–450PubMedCrossRef
32.
Zurück zum Zitat Bosaeus I (2008) Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 16(5):447–451PubMedCrossRef Bosaeus I (2008) Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 16(5):447–451PubMedCrossRef
33.
Zurück zum Zitat Berry DP, Charnley RM, Dervenis C, Kirk GR, Regan F, Yekebas EF, Imrie CW (2011) Pain management and nutritional support in nonresectable pancreatic cancer. In: Johnson CD, Imrie CW (eds) Pancreatic disease. Springer London, pp 73-77. doi:10.1007/978-1-84882-118-7_8 Berry DP, Charnley RM, Dervenis C, Kirk GR, Regan F, Yekebas EF, Imrie CW (2011) Pain management and nutritional support in nonresectable pancreatic cancer. In: Johnson CD, Imrie CW (eds) Pancreatic disease. Springer London, pp 73-77. doi:10.​1007/​978-1-84882-118-7_​8
34.
Zurück zum Zitat Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ (1998) Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 42(1):92–96PubMedCrossRef Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ (1998) Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 42(1):92–96PubMedCrossRef
35.
Zurück zum Zitat Sarhill N, Mahmoud F, Walsh D, Nelson KA, Komurcu S, Davis M, LeGrand S, Abdullah O, Rybicki L (2003) Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 11(10):652–659. doi:10.1007/s00520-003-0486-0 PubMedCrossRef Sarhill N, Mahmoud F, Walsh D, Nelson KA, Komurcu S, Davis M, LeGrand S, Abdullah O, Rybicki L (2003) Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 11(10):652–659. doi:10.​1007/​s00520-003-0486-0 PubMedCrossRef
36.
Zurück zum Zitat Petruson KM, Silander EM, Hammerlid EB (2005) Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 27(4):302–310PubMedCrossRef Petruson KM, Silander EM, Hammerlid EB (2005) Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 27(4):302–310PubMedCrossRef
37.
Zurück zum Zitat Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377–382PubMed Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377–382PubMed
38.
Zurück zum Zitat Chate A (2006) A pilot audit of weight loss in upper gastrointestinal oncology outpatients. J Hum Nutr Diet 19(6):447–450PubMedCrossRef Chate A (2006) A pilot audit of weight loss in upper gastrointestinal oncology outpatients. J Hum Nutr Diet 19(6):447–450PubMedCrossRef
40.
Zurück zum Zitat Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38(7):680–685PubMedCrossRef Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38(7):680–685PubMedCrossRef
41.
Zurück zum Zitat Sreebny LM, Schwartz SS (1997) A reference guide to drugs and dry mouth—2nd edition. Gerodontology 14(1):33–47PubMedCrossRef Sreebny LM, Schwartz SS (1997) A reference guide to drugs and dry mouth—2nd edition. Gerodontology 14(1):33–47PubMedCrossRef
42.
Zurück zum Zitat Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11(4):226–231PubMed Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11(4):226–231PubMed
45.
Zurück zum Zitat Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163PubMedCrossRef Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163PubMedCrossRef
Metadaten
Titel
Symptoms in advanced pancreatic cancer are of importance for energy intake
verfasst von
Asta Bye
Marit S. Jordhøy
Grete Skjegstad
Oddlaug Ledsaak
Per Ole Iversen
Marianne Jensen Hjermstad
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1514-8

Weitere Artikel der Ausgabe 1/2013

Supportive Care in Cancer 1/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.